Kenyan Health Patient Information Leaflet
Vitamin / mineral / nutritional supplement
Magnesium deficiency and hypomag- nesaemia; seizures in eclampsia; convulsion in acute uraemia; premature labour; myocardial infarction Clinical selection for Magnesium Sulphate injection should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Vitamin / mineral / nutritional supplement. Confirm site-specific dose, duration and monitoring before prescribing.
Seizures in eclampsia: a variety of doses have been employed. It can be given IM as heptahydrate at a dose of up to 5gm. Also adminis- tered by IV inf in glucose 5% in dosage not exceeding 30 to 40gm daily [dose reduced in cases of renal failure]. Hypomagnesaemia [severe]: IV inf in glucose 5% in dosage not exceeding 35 to 75 mmol on the first day followed by 25mmol daily [max 160mmol].
Allergic reactions; hypermagnesaemia [symptoms of which are nausea, vomiting; flushing, thirst, hypotension due to peripheral vasodilatation, drowsiness, confusion, arrhythmias, loss of tendon reflexes due to neuromuscular blocking agents, coma, cardiac arrest, muscle weakness, respiratory depression
Store as labelled. Keep out of reach of children.